Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Core Scientific, Inc./tx Filed by: Valiant Capital Management, L.P.

May 15, 2026 7:46 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 317,885,292 shares of Common Stock outstanding as of May 1, 2026, as reported in the Form 10-Q filed by the Issuer for the fiscal year ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 317,885,292 shares of Common Stock outstanding as of May 1, 2026, as reported in the Form 10-Q filed by the Issuer for the fiscal year ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 317,885,292 shares of Common Stock outstanding as of May 1, 2026, as reported in the Form 10-Q filed by the Issuer for the fiscal year ended March 31, 2026.


SCHEDULE 13G



Valiant Capital Management, L.P.
Signature:/s/ Michaela Beckman
Name/Title:Chief Compliance Officer
Date:05/15/2026
Valiant Capital Management, LLC
Signature:/s/ Michaela Beckman
Name/Title:Chief Compliance Officer
Date:05/15/2026
Christopher R. Hansen
Signature:/s/ Christopher R. Hansen
Name/Title:Reporting person
Date:05/15/2026
Exhibit Information

Exhibit 99 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

ATTACHMENTS / EXHIBITS

ex99.htm

Categories

SEC Filings